Canadian Pharmaceutical Channel Intelligence
AnalysisThe WireConnectorAbout
Sign inGet the Connector
Analysis·CADTH / INESSS

CADTH's conditional recommendation isn't about the drug. It's a message to the provinces.

Read the reimbursement conditions as an opening negotiating position, not a clinical verdict — and watch who blinks first.

The event

CADTH issued a conditional reimbursement recommendation for an oncology agent, contingent on a price reduction and defined clinical criteria.

A conditional recommendation looks like a clinical judgment with strings attached. It's better understood as a lever. The clinical question was effectively settled the moment the recommendation said "reimburse"; everything after the comma is about price and leverage.

Keep reading — free

Create a free account to read the full interpretation.

You’ve reached the part where The Indication earns its name — the read on distribution, reimbursement timing, and channel strategy. It’s free to finish: sign in or create an account to keep reading every analysis in full.

Want to query the archive from your own AI assistant instead? That’s the Connector (paid).